Vancomycin Treatment of Infective Endocarditis Is Linked with Recently Acquired Obesity
Franck Thuny, Hervé Richet, Jean-Paul Casalta et al. · 2010
Read Vancomycin Treatment of Infective Endocarditis Is Linked with Recently Acquired Obesity by Franck Thuny, Hervé Richet, Jean-Paul Casalta et al. (2010) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0009074.txt.
Description
Franck Thuny and co-authors linked a strong antibiotic given for heart infection to later weight gain, in PLOS ONE in 2010. Vancomycin treats infective endocarditis, an infection of the heart's inner lining. Gut microbes help decide how much energy food yields. A vancomycin-like drug, avoparcin, was long used to fatten farm animals.
The team tested whether patients gained weight after vancomycin treatment. Recently acquired obesity appeared linked to the therapy. Wiping out gut bacteria may change how much energy patients harvest. The finding adds weight to worries about antibiotics' wider body effects.
Catalog record
| CREATOR | Franck Thuny, Hervé Richet, Jean-Paul Casalta et al. |
|---|---|
| YEAR | 2010 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 27 KB |
| LICENSE | Creative Commons Attribution License |
| RIGHTS | CC BY |
| SOURCE | PLOS ONE |
Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0009074